BTN3A1 regulate the function of Vγ9Vδ2 T cells through TCR signaling pathway in ovarian cancer

This preclinical study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

This preclinical study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

What the study was

Study design

Preclinical study

Maturity

Exploratory

Journal

Journal of ovarian research

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.